Klánová, M., Kazantsev, D., Pokorná, E., Zikmund, T., Karolová, J., Behounek, M., Renesova, N., Sovilj, D., Kelemen, C. D., Helman, K., Jaksa, R., Havranek, O., Anděra, L., Trněný, M., Klener, P. Anti-apoptotic MCL1 Protein Represents Critical Survival Molecule for Most Burkitt Lymphomas and BCL2-negative Diffuse Large B-cell Lymphomas. Molecular Cancer Therapeutics. 2022, 21(1), 89-99. ISSN 1535-7163. E-ISSN 1538-8514. Dostupné z: https://doi.org/10.1158/1535-7163.MCT-21-0511.